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No one would contest that Australia is a country that 
has plenty of sun. We pay for this with the highest 
prevalence of skin cancer in the world with two out of 
three Australians being treated for skin cancer in their 
lifetime.1 However, public health messages to reduce 
sun exposure must be balanced with maintaining 
adequate vitamin D levels,2 especially given Australia’s 
multicultural and aging population. People who 
come to Australia as refugees are particularly at risk, 
with approximately 40–80% prevalence of vitamin D 
deficiency in refugee health centres across Australia.3 
	
There	 is	 a	 growing	 body	 of	 Australian	 research	 on	
asymptomatic	 vitamin	D	deficiency	 in	 the	elderly,	women	
who	wear	 a	 veil	 for	 cultural	 reasons,	 and	migrants	 from	
Africa	as	well	 as	 in	healthy	children	who	spend	more	 time	
indoors.4,5	One	study	of	 veiled	 and	dark	 skinned	pregnant	




seems	 to	 be	 particularly	 common	 in	 refugees	 from	East	
Africa	who	have	spent	time	in	Egypt	where	the	prevalence	
of	vitamin	D	deficiency	has	been	found	to	be	100%.3
	 Vitamin	D	 is	 not	 really	 a	 vitamin	but	 a	 neurohormone	
that	 is	 important	 for	 calcium	metabolism,	 bone	 growth,	
immune	 function,	gene	stability,	muscle	 function	and	brain	
development.	It	is	derived	predominantly	through	the	action	
of	 ultraviolet	 (UV)	 light	 on	precursors	 in	 the	 skin	but	may	
also	be	absorbed	 through	 the	gut	 from	oily	 fish	and	eggs.	
It	 is	 then	 further	metabolised	 in	 the	 liver	 and	 kidney.	The	
two	forms	of	vitamin	D	are	cholecalciferol	 (vitamin	D3)	and	
ergocalciferol	 (vitamin	D2).	Levels	of	 serum	25-OH	vitamin	
D3	 are	 used	 as	 the	 indicator	 of	 vitamin	D	 status.7	 Lips	
classifies	a	 level	of	25-OH	vitamin	D	above	50	nmol/L	 (20	
ng/mL)	 as	normal,	 26–50	nmol/L	 (10–20	ng/mL)	 as	 a	mild	





Other	populations	at	 risk	of	deficiency	 include:	 those	with	
decreased	 sun	 exposure	 because	 of	 lack	 of	 time	 spent	
outdoors	 (an	 increasingly	 common	situation	 in	 developed	
settings),	 those	 covered	extensively	 by	 clothing,	 as	 seen	
most	 profoundly	 in	women	observing	 purdah,	 and	 those	
with	gut	absorption	problems	or	who	have	a	diet	deficient	







Vitamin	 D	 deficiency	 most	 commonly	 presents	
asymptomatically.	 However,	 it	 may	 also	 present	
as	 osteoporosis	 or	 its	 complications,	 particularly	 in	
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postmenopausal	women	and	 the	elderly,	 and	as	
rickets,	 delayed	walking,	 leg	 bowing,	 seizures	
or	 failure	 to	 thrive	 in	 children.2,16,17,20	 Infants	 of	
women	 who	 are	 vitamin	 D	 deficient	 during	
pregnancy	will	usually	also	be	vitamin	D	deficient	
and	 hence	 at	 an	 increased	 risk	 of	 both	 short	
and	 long	 term	 sequelae.2,6,21	 In	 addition	 to	 the	
well	established	dysfunction	of	bone	and	muscle	
metabolism,	 vitamin	 D	 has	 been	 linked	with	
a	wide	 range	 of	 other	 illnesses.	These	 include	
diabetes,	schizophrenia,	prostate	cancer,	multiple	
sclerosis	and	autoimmune	disorders.15,22–25
	 Less	 well	 known,	 but	 well	 established	
in	 the	 literature,	 is	 the	 prevalence	 of	muscle	
pain	 and	weakness	 as	 a	 result	 of	 vitamin	 D	
deficiency.14,16,17,26,27	 In	Australia,	muscle	 pain	 in	
particular	 appears	 to	 be	 a	 problem	 in	 refugee	







symptoms,	with	 a	 range	of	 ‘serious	 therapeutic	
consequences’	for	some.28	
Treatment 
Up	 to	500	000	 IU	of	 vitamin	D	may	be	needed	
to	replenish	stores	in	those	who	are	deficient.2,29	
Recent	Australian	 studies	 on	 the	 efficacy	 and	
safety	 of	 ‘stoss	 therapy’	 –	 which	 involves	
megadoses	of	cholecalciferol	given	intramuscularly	
or	 orally	 according	 to	 a	 standard	 protocol	 –	 to	
treat	 vitamin	D	deficiency	concluded	 that	 this	 is	
safe,	 effective	 and	 cost	 beneficial	 compared	 to	
the	 oral	 ergocalciferol	 currently	 available.2,29,30	
Treatment	protocols	are	also	available	 for	 infants	
and	pregnant	women	who	are	vitamin	D	deficient	
using	 higher	 doses	 of	 vitamin	 D.2,21	 Other	
studies	have	shown	 that	 complete	 resolution	of	
symptoms,	including	muscle	pain	and	weakness,	
can	 be	 rapid	when	 adequate	 doses	 are	 given	
to	 those	with	moderate	 to	 severe	 deficiency.26	
Both	 in	 this	 author’s	 clinical	 experience	 and	 in	
case	 reports	 from	 the	 literature,	 patients	 have	







Some	hospitals	 and	 compounding	 pharmacies	





and	 long	 term	 sequelae.	Often	 the	 deficiency	
is	 asymptomatic	 or	 presents	with	 symptoms	
such	 as	muscle	 pain,	 therefore	 it	 is	 important	
that	general	practitioners	consider	 the	diagnosis	
based	on	 risk	 factors	 and	maintain	 a	high	 index	
of	suspicion.	In	particular,	serum	vitamin	D	levels	
should	 be	part	 of	 the	 initial	 health	 assessment	
of	 all	 refugees	 and	 health	 providers	 should	





A 38 year old Middle Eastern refugee with severe postnatal depression spent 
12 months in and out of psychiatric hospitals and immigration detention 
centres. She had been immobile in bed or in a wheelchair for 8 months with 
severe pain, weakness and allodynia (extreme sensitivity to touch) such that 
it was difficult to distinguish if her condition was physical or psychological. 
Her 25-OH vitamin D was 15 nmol/L (60–160), alkaline phosphatase 342 U/L 
(30–110), and parathyroid hormone 34.3 pmol/L (0.8–5.5). She was treated 
with Ostelin 1000 (ergocalciferol) twice per day, and because she had 
pseudofractures, she was also given calcium carbonate 1500 mg (Caltrate, 
equivalent to 600 mg calcium) twice per day and alendronate 70 mg 
(Fosamax) weekly. 
Six months after beginning this regimen she was still wheelchair bound and 
was taking morphine in the form of MS Contin 30 mg twice per day for her 
severe leg pain. She had not left the house and was being visited at home by 
her psychiatrist and physiotherapist. She was given cholecalciferol powder 
50 000 IU from the hospital for three doses at two weekly intervals for her 
inadequately treated vitamin D deficiency. Her improvement was dramatic and 
6 weeks later she had stopped her MS Contin and was walking unaided. 
Twelve months later, she has had another child and has remained well, with a 
normal vitamin D level of 59 nmol/L, ALP 188 U/L, and PTH 6.1 pmol/L.
Table 1. Vitamin D deficiency screening and follow up 
Measure serum 25-OH vitamin D/ALP/Ca/phosphate
25-OH vitamin D >50 nmol/L
No treatment necessary
25-OH vitamin D 25–50 nmol/L 
100 000 IU–150 000 IU stat vitamin D orally or IMI if available2,29,30
OR
500–1000 IU/day oral cholecalciferol or ergocalciferol (this dose is also safe for 
newborns and pregnant women)2,21
Repeat vitamin D level/ALP/PTH after 2–3 months and repeat dose as necessary until 
blood tests are normal 
25-OH vitamin D <25 nmol/L
Treatment and follow up as above, plus:
•  If over 40 years of age or any suspicion of pathological fractures do bone density 
studies
•  If less than 15 years of age or any evidence of rickets or abnormal bone growth do 
hand/wrist/knee X-rays and refer to a children’s hospital
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